A citation-based method for searching scientific literature

Markus Mordstein, Georg Kochs, Laure Dumoutier, Jean-Christophe Renauld, Søren R Paludan, Kevin Klucher, Peter Staeheli. PLoS Pathog 2008
Times Cited: 237







List of co-cited articles
1076 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.
Markus Mordstein, Eva Neugebauer, Vanessa Ditt, Birthe Jessen, Toni Rieger, Valeria Falcone, Frederic Sorgeloos, Stephan Ehl, Daniel Mayer, Georg Kochs,[...]. J Virol 2010
269
50

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.
Caroline Sommereyns, Sophie Paul, Peter Staeheli, Thomas Michiels. PLoS Pathog 2008
520
45

IL-28, IL-29 and their class II cytokine receptor IL-28R.
Paul Sheppard, Wayne Kindsvogel, Wenfeng Xu, Katherine Henderson, Stacy Schlutsmeyer, Theodore E Whitmore, Rolf Kuestner, Ursula Garrigues, Carl Birks, Jenny Roraback,[...]. Nat Immunol 2003
39

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
Sergei V Kotenko, Grant Gallagher, Vitaliy V Baurin, Anita Lewis-Antes, Meiling Shen, Nital K Shah, Jerome A Langer, Faruk Sheikh, Harold Dickensheets, Raymond P Donnelly. Nat Immunol 2003
38

Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.
Stefania Crotta, Sophia Davidson, Tanel Mahlakoiv, Christophe J Desmet, Matthew R Buckwalter, Matthew L Albert, Peter Staeheli, Andreas Wack. PLoS Pathog 2013
162
37

IFN-lambda determines the intestinal epithelial antiviral host defense.
Johanna Pott, Tanel Mahlakõiv, Markus Mordstein, Claudia U Duerr, Thomas Michiels, Silvia Stockinger, Peter Staeheli, Mathias W Hornef. Proc Natl Acad Sci U S A 2011
277
35

Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections.
Tanel Mahlakõiv, Pedro Hernandez, Konrad Gronke, Andreas Diefenbach, Peter Staeheli. PLoS Pathog 2015
117
32

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.
Timothy J Nice, Megan T Baldridge, Broc T McCune, Jason M Norman, Helen M Lazear, Maxim Artyomov, Michael S Diamond, Herbert W Virgin. Science 2015
203
31

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
Ioanna E Galani, Vasiliki Triantafyllia, Evridiki-Evangelia Eleminiadou, Ourania Koltsida, Athanasios Stavropoulos, Maria Manioudaki, Dimitris Thanos, Sean E Doyle, Sergei V Kotenko, Kalliopi Thanopoulou,[...]. Immunity 2017
193
29

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.
Nina Ank, Marie B Iversen, Christina Bartholdy, Peter Staeheli, Rune Hartmann, Uffe B Jensen, Frederik Dagnaes-Hansen, Allan R Thomsen, Zhi Chen, Harald Haugen,[...]. J Immunol 2008
319
27

IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.
Sophia Davidson, Teresa M McCabe, Stefania Crotta, Hans Henrik Gad, Edith M Hessel, Soren Beinke, Rune Hartmann, Andreas Wack. EMBO Mol Med 2016
113
25

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.
Katrina Blazek, Hayley L Eames, Miriam Weiss, Adam J Byrne, Dany Perocheau, James E Pease, Sean Doyle, Fiona McCann, Richard O Williams, Irina A Udalova. J Exp Med 2015
129
23

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
Ludmila Prokunina-Olsson, Brian Muchmore, Wei Tang, Ruth M Pfeiffer, Heiyoung Park, Harold Dickensheets, Dianna Hergott, Patricia Porter-Gill, Adam Mumy, Indu Kohaar,[...]. Nat Genet 2013
627
23

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.
Nancy A Jewell, Troy Cline, Sara E Mertz, Sergey V Smirnov, Emilio Flaño, Christian Schindler, Jessica L Grieves, Russell K Durbin, Sergei V Kotenko, Joan E Durbin. J Virol 2010
177
23

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
Helen M Lazear, Timothy J Nice, Michael S Diamond. Immunity 2015
230
22

Guarding the frontiers: the biology of type III interferons.
Andreas Wack, Ewa Terczyńska-Dyla, Rune Hartmann. Nat Immunol 2015
178
22

IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission.
Jonas Klinkhammer, Daniel Schnepf, Liang Ye, Marilena Schwaderlapp, Hans Henrik Gad, Rune Hartmann, Dominique Garcin, Tanel Mahlakõiv, Peter Staeheli. Elife 2018
104
22

Pathogenic potential of interferon αβ in acute influenza infection.
Sophia Davidson, Stefania Crotta, Teresa M McCabe, Andreas Wack. Nat Commun 2014
192
21

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Nina Ank, Hans West, Christina Bartholdy, Kristina Eriksson, Allan R Thomsen, Søren R Paludan. J Virol 2006
434
20

Innate immunity to influenza virus infection.
Akiko Iwasaki, Padmini S Pillai. Nat Rev Immunol 2014
487
19

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection.
Pedro P Hernández, Tanel Mahlakoiv, Ines Yang, Vera Schwierzeck, Nam Nguyen, Fabian Guendel, Konrad Gronke, Bernhard Ryffel, Christoph Hoelscher, Laure Dumoutier,[...]. Nat Immunol 2015
174
18


IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function.
Achille Broggi, Yunhao Tan, Francesca Granucci, Ivan Zanoni. Nat Immunol 2017
90
18

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.
Sean E Doyle, Heidi Schreckhise, Kien Khuu-Duong, Katherine Henderson, Robert Rosler, Harold Storey, Lena Yao, Hong Liu, Fariba Barahmand-pour, Pallavur Sivakumar,[...]. Hepatology 2006
283
16

Diverse intracellular pathogens activate type III interferon expression from peroxisomes.
Charlotte Odendall, Evelyn Dixit, Fabrizia Stavru, Helene Bierne, Kate M Franz, Ann Fiegen Durbin, Steeve Boulant, Lee Gehrke, Pascale Cossart, Jonathan C Kagan. Nat Immunol 2014
223
16

Interferon-stimulated genes: a complex web of host defenses.
William M Schneider, Meike Dittmann Chevillotte, Charles M Rice. Annu Rev Immunol 2014
16

Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.
Megan T Baldridge, Timothy J Nice, Broc T McCune, Christine C Yokoyama, Amal Kambal, Michael Wheadon, Michael S Diamond, Yulia Ivanova, Maxim Artyomov, Herbert W Virgin. Science 2015
213
16

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.
Ourania Koltsida, Michael Hausding, Athanasios Stavropoulos, Sonja Koch, George Tzelepis, Caroline Ubel, Sergei V Kotenko, Paschalis Sideras, Hans A Lehr, Marcus Tepe,[...]. EMBO Mol Med 2011
137
16

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.
Jian-Da Lin, Ningguo Feng, Adrish Sen, Murugabaskar Balan, Hsiang-Chi Tseng, Constance McElrath, Sergey V Smirnov, Jianya Peng, Linda L Yasukawa, Russell K Durbin,[...]. PLoS Pathog 2016
71
22


Type I interferons in infectious disease.
Finlay McNab, Katrin Mayer-Barber, Alan Sher, Andreas Wack, Anne O'Garra. Nat Rev Immunol 2015
857
15

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Tobias Marcello, Arash Grakoui, Giovanna Barba-Spaeth, Erica S Machlin, Sergei V Kotenko, Margaret R MacDonald, Charles M Rice. Gastroenterology 2006
449
14

Virus interference. I. The interferon.
A ISAACS, J LINDENMANN. Proc R Soc Lond B Biol Sci 1957
14

Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.
Megan T Baldridge, Sanghyun Lee, Judy J Brown, Nicole McAllister, Kelly Urbanek, Terence S Dermody, Timothy J Nice, Herbert W Virgin. J Virol 2017
77
18

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.
Andrew J Muir, Sanjeev Arora, Gregory Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein,[...]. J Hepatol 2014
86
15

Functional role of type I and type II interferons in antiviral defense.
U Müller, U Steinhoff, L F Reis, S Hemmi, J Pavlovic, R M Zinkernagel, M Aguet. Science 1994
12

Interferon induction and function at the mucosal surface.
Russell K Durbin, Sergei V Kotenko, Joan E Durbin. Immunol Rev 2013
137
12


Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.
Helen M Lazear, Brian P Daniels, Amelia K Pinto, Albert C Huang, Sarah C Vick, Sean E Doyle, Michael Gale, Robyn S Klein, Michael S Diamond. Sci Transl Med 2015
128
12

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
Nikolaus Jilg, Wenyu Lin, Jian Hong, Esperance A Schaefer, David Wolski, James Meixong, Kaku Goto, Cynthia Brisac, Pattranuch Chusri, Dahlene N Fusco,[...]. Hepatology 2014
71
15

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Dongliang Ge, Jacques Fellay, Alexander J Thompson, Jason S Simon, Kevin V Shianna, Thomas J Urban, Erin L Heinzen, Ping Qiu, Arthur H Bertelsen, Andrew J Muir,[...]. Nature 2009
11

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.
Adrian Egli, Deanna M Santer, Daire O'Shea, Khaled Barakat, Mohammedyaseen Syedbasha, Madeleine Vollmer, Aliyah Baluch, Rakesh Bhat, Jody Groenendyk, Michael A Joyce,[...]. PLoS Pathog 2014
66
16

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.
Zhiwei Yin, Jihong Dai, Jing Deng, Faruk Sheikh, Mahwish Natalia, Tiffany Shih, Anita Lewis-Antes, Sheela B Amrute, Ursula Garrigues, Sean Doyle,[...]. J Immunol 2012
114
11

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses.
Ole J Hamming, Ewa Terczyńska-Dyla, Gabrielle Vieyres, Ronald Dijkman, Sanne E Jørgensen, Hashaam Akhtar, Piotr Siupka, Thomas Pietschmann, Volker Thiel, Rune Hartmann. EMBO J 2013
134
10

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
Laure Dumoutier, Amel Tounsi, Thomas Michiels, Caroline Sommereyns, Sergei V Kotenko, Jean-Christophe Renauld. J Biol Chem 2004
248
10

Mx GTPases: dynamin-like antiviral machines of innate immunity.
Otto Haller, Peter Staeheli, Martin Schwemmle, Georg Kochs. Trends Microbiol 2015
215
10

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.
Adrian Egli, Deanna M Santer, Daire O'Shea, D Lorne Tyrrell, Michael Houghton. Emerg Microbes Infect 2014
95
10

Role of deficient type III interferon-lambda production in asthma exacerbations.
Marco Contoli, Simon D Message, Vasile Laza-Stanca, Michael R Edwards, Peter A B Wark, Nathan W Bartlett, Tatiana Kebadze, Patrick Mallia, Luminita A Stanciu, Hayley L Parker,[...]. Nat Med 2006
717
10

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.
Irving C Allen, Margaret A Scull, Chris B Moore, Eda K Holl, Erin McElvania-TeKippe, Debra J Taxman, Elizabeth H Guthrie, Raymond J Pickles, Jenny P-Y Ting. Immunity 2009
709
10

Type III interferon is a critical regulator of innate antifungal immunity.
Vanessa Espinosa, Orchi Dutta, Constance McElrath, Peicheng Du, Yun-Juan Chang, Bryan Cicciarelli, Amy Pitler, Ian Whitehead, Joshua J Obar, Joan E Durbin,[...]. Sci Immunol 2017
74
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.